Defibrillator Coverage Decision Will Weigh DEFINITE, COMPANION Trials
This article was originally published in The Gray Sheet
Executive Summary
St. Jude Medical estimates the worldwide market for high-voltage cardiac rhythm management devices will approach $4.7 bil. by year-end, growing 20% over the 2003 level, based on published peer-reviewed studies and a potentially broader Medicare coverage policy